Login / Signup

CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma.

Yelei GuoChuan TongLiping SuWenying ZhangHejin JiaYang LiuQingming YangZhiqiang WuYao WangWeidong Han
Published in: Blood advances (2022)
Keyphrases
  • crispr cas
  • diffuse large b cell lymphoma
  • genome editing
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • hodgkin lymphoma
  • genome wide
  • gene expression